STAT+: Pharmalittle: We’re reading about Trump and pharma tariffs, an abortion pill ruling, and more
1 week 1 day ago
Pharma, Pharmalot, pharmalittle, STAT+
STAT+: Pharmalittle: We’re reading about Regeneron’s patent maneuvers, FDA rejection letters, and lots more
2 weeks 6 hours ago
Pharma, Pharmalot, pharmalittle, STAT+
STAT+: Pharmalittle: We’re reading about Spain probing Novo weight loss ads, AstraZeneca stock listing, and more
3 weeks 1 day ago
Pharma, Pharmalot, pharmalittle, STAT+
STAT+: Pharmalittle: We’re reading about Novo’s Wegovy launch gaffes, a former Pfizer exec’s subpoena, and more
3 weeks 2 days ago
Pharma, Pharmalot, pharmalittle, STAT+
STAT+: AbbVie snaps up CAR-T company in a deal worth $2.1 billion
3 weeks 3 days ago
Biotech, AbbVie, autoimmune, biotechnology, Cancer, Pharmaceuticals, STAT+
STAT+: Pharmalittle: We’re reading about a new FDA review program, proposed DTC ad changes, and more
1 month 6 days ago
Pharmalot, pharmalittle, STAT+
STAT+: Pharmalittle: We’re reading about a Sarepta setback with a DMD drug, FDA workload causes a delay, and more
1 month 1 week ago
Pharmalot, pharmalittle, STAT+
Opinion: STAT+: RFK Jr. acknowledges receiving unproven stem cell treatment from an Antigua clinic
1 month 2 weeks ago
First Opinion, Lab Dish, biotechnology, gene therapy, RFK Jr., STAT+, stem cells
STAT+: More Medicare plans cover Humira biosimilars, but do little to encourage patient use
2 months 2 weeks ago
Pharmalot, Biosimilars, biotechnology, drug pricing, humira, Medicare, Pharmaceuticals, Public Health, STAT+
STAT+: Trump nominates Casey Means, entrepreneurial doctor and MAHA leader, for surgeon general
2 months 2 weeks ago
Health, Politics, chronic disease, Donald Trump, Politics, RFK Jr., STAT+, White House